BIM
CLVS

BlackRock Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

BlackRock Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.28M Sell
118,871
-410
-0.3% -$14.4K 0.01% 1559
2016
Q3 		$4.3M Buy
119,281
+1,831
+2% +$39.3K 0.01% 1588
2016
Q2 		$1.61M Buy
117,450
+22,449
+24% +$328K ﹤0.01% 2282
2016
Q1 		$1.82M Buy
95,001
+1,579
+2% +$33.4K ﹤0.01% 2070
2015
Q4 		$3.27M Sell
93,422
-13,654
-13% -$881K ﹤0.01% 1712
2015
Q3 		$9.85M Buy
107,076
+9,009
+9% +$780K 0.01% 940
2015
Q2 		$8.62M Buy
98,067
+16,948
+21% +$1.45M 0.01% 1104
2015
Q1 		$6.02M Sell
81,119
-4,870
-6% -$344K 0.01% 1249
2014
Q4 		$4.82M Sell
85,989
-462
-0.5% -$24.3K 0.01% 1384
2014
Q3 		$3.92M Buy
86,451
+19,032
+28% +$795K 0.01% 1514
2014
Q2 		$2.79M Buy
67,419
+17,896
+36% +$922K ﹤0.01% 1815
2014
Q1 		$3.43M Buy
49,523
+357
+0.7% +$26.2K 0.01% 1664
2013
Q4 		$2.96M Buy
49,166
+4,292
+10% +$233K ﹤0.01% 1734
2013
Q3 		$2.73M Buy
44,874
+6,735
+18% +$478K ﹤0.01% 1724
2013
Q2 		$2.56M Buy
+38,139
New +$1.72M ﹤0.01% 1683

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Investment Management's CLVS Position: Q4 2016 in Review

BlackRock Investment Management reduced its Clovis Oncology, Inc. (CLVS) stake by 0.34% in Q4 2016, selling an estimated $14.4K and leaving 118,871 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #1559.

BlackRock Investment Management first reported a position in CLVS in Q2 2013 and has held it in 15 quarters since. The position peaked at $9.85M in Q3 2015. 167 funds tracked by Wall St. Rank hold CLVS as of Q4 2016.

  • BlackRock Investment Management held 118,871 shares of Clovis Oncology, Inc. worth $5.28M as of Q4 2016.
  • BlackRock Investment Management sold 410 Clovis Oncology, Inc. shares in Q4 2016, an estimated $14.4K.
  • Clovis Oncology, Inc. made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1559 holding.
  • BlackRock Investment Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Clovis Oncology, Inc. position peaked at $9.85M in Q3 2015.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.